AltheaDx Raising $6M
AltheaDx, a San Diego company previously known as Althea Diagnostics, has garnered $3.57 million in a recent venture round that aims to raise a total of $6 million, according to a recent regulatory filing. The company provides services and technologies to streamline drug development. The paperwork does not identify the investors, although AltheaDx identifies Telegraph Hill Partners on its website as its longtime principal investor. The company offers a range of molecular testing technologies and services, including biomarker discovery and development for biopharma customers, diagnostic translation, and clinical genotyping of the K-RAS gene and other clinical testing services for physicians.